US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Theriva Biologics

0.1802

-0.0165-8.39%

Post-market: 0.1731-0.0071-3.97%19:59 EST

Volume:17.11M

Turnover:3.22M

Market Cap:6.43M

PE:-0.03

High:0.1988

Open:0.1863

Low:0.1700

Close:0.1967

52wk High:1.60

52wk Low:0.1651

Shares:35.69M

Float Shares:34.94M

Volume Ratio:0.30

T/O Rate:48.97%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-5.5306

EPS(LYR):-19.0286

ROE:-166.96%

ROA:-29.21%

PB:0.95

PE(LYR):-0.01

Loading ...

Overview Company News Filings

BRIEF-Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications

Theriva Biologics licenses SYN-020 to Rasayana Therapeutics

Theriva Biologics Inc: Received $300,000 Upfront Payment at Signing & Eligible for up to $38M in Milestone Payments

THOMSON REUTERS

Theriva™ Biologics Licenses Syn-020 to Rasayana Therapeutics for Multiple Indications

THOMSON REUTERS

Theriva Biologics Licenses SYN-020 to Rasayana Therapeutics in $38M Milestone Deal

Theriva Biologics Delays Shareholder Vote on Issuance of 16.2 Million Warrant Shares

Theriva Biologics stellt Phase-1-Studienergebnisse zu VCN-01 bei refraktärem Retinoblastom vor

Theriva™ Biologics Announces Upcoming Presentation of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial at Apao 2026

THOMSON REUTERS

Why Is Theriva Biologics Stock Gaining Monday?

Benzinga_recent_news

Theriva Biologics Inc - Cash Runway Until Q1 2027 Supports Vcn-01 Trials

THOMSON REUTERS

Theriva™ Biologics Announces Positive Scientific Advice From the European Medicines Agency (Ema) on the Design of a Phase 3 Trial of Vcn-01 in Metastatic Pancreatic Ductal Adenocarcinoma (Pdac)

THOMSON REUTERS

Theriva Biologics Inc - to Schedule End-of-Phase 2 Meeting With FDA in H1 2026

THOMSON REUTERS

Theriva Biologics Seeks Shareholder Approval for Issuance of 16.2 Million Shares Under Warrant Agreement

Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year

Theriva Biologics Q3 EPS $(0.45) Beats $(1.13) Estimate

Theriva Biologics reports third quarter loss and lower R&D expenses

Theriva Biologics Inc. Announces Date for Upcoming Special Stockholders Meeting

Theriva Biologics: No Material Development to Account for Stock Activity

Theriva Biologics sees no material development to account for unusual trading

Theriva Biologics Provides Response to Unusual Market Action

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TOVX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TOVX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOVX\",,,,,undefined,":{"symbol":"TOVX","market":"US","secType":"STK","nameCN":"Theriva Biologics","latestPrice":0.1802,"timestamp":1771621200000,"preClose":0.1967,"halted":0,"volume":17109331,"hourTrading":{"tag":"盘后","latestPrice":0.17305,"preClose":0.1802,"latestTime":"19:59 EST","volume":745340,"amount":131130.469998,"timestamp":1771635588721,"change":-0.00715,"changeRate":-0.039678,"amplitude":0.04495},"delay":0,"changeRate":-0.08388408744280637,"floatShares":34939100,"shares":35688300,"eps":-5.5306,"marketStatus":"Market Closed","change":-0.0165,"latestTime":"02-20 16:00:00 EST","open":0.1863,"high":0.1988,"low":0.17,"amount":3219256.8179247603,"amplitude":0.146416,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.5306,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"AMEX","adjPreClose":0.1967,"preHourTrading":{"tag":"盘前","latestPrice":0.1862,"preClose":0.1967,"latestTime":"09:29 EST","volume":2851272,"amount":541610.43594984,"timestamp":1771597798035,"change":-0.0105,"changeRate":-0.053381,"amplitude":0.126589},"postHourTrading":{"tag":"盘后","latestPrice":0.17305,"preClose":0.1802,"latestTime":"19:59 EST","volume":745340,"amount":131130.469998,"timestamp":1771635588721,"change":-0.00715,"changeRate":-0.039678,"amplitude":0.04495},"volumeRatio":0.2989451217198191},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TOVX\",,,,,undefined,":{"symbol":"TOVX","floatShares":34939100,"roa":"-29.21%","roe":"-166.96%","lyrEps":-19.028636,"volumeRatio":0.2989451217198191,"shares":35688300,"dividePrice":0,"high":0.1988,"amplitude":0.146416,"preClose":0.1967,"low":0.17,"week52Low":0.1651,"pbRate":"0.95","week52High":1.5999,"institutionHeld":0.0219,"latestPrice":0.1802,"eps":-5.5306,"divideRate":0,"volume":17109331,"delay":0,"ttmEps":-5.5306,"open":0.1863,"prevYearClose":0.2104,"prevWeekClose":0.182,"prevMonthClose":0.18,"prevQuarterClose":0.2104,"fiveDayClose":0.1805,"twentyDayClose":0.2069,"sixtyDayClose":0.216},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TOVX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-12","symbol":"TOVX","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762923600000,"reportTimeType":"pre","actualEps":-0.45},{"market":"US","date":"2025-08-11","symbol":"TOVX","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"pre","actualEps":-1.93},{"market":"US","date":"2025-05-14","symbol":"TOVX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"pre","actualEps":-1.55},{"market":"US","date":"2025-03-06","symbol":"TOVX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741237200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-12","symbol":"TOVX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"pre","actualEps":-6.81}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TOVX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TOVX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":2,"updateTime":1746766800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TOVX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TOVX","date":"2026-02-20","current":-0.032582,"percent":0.695192,"low":-11.860366,"twenty":-3.135609,"median":-0.486305,"eighty":-0.161746,"high":-0.056131,"avg":-1.767765,"sd":2.498977,"marketCap":7014231},"quantilePoints":[{"date":"2021-02-26","current":-6.398521,"twenty":-1.931483,"median":-0.667779,"eighty":-0.508474,"marketCap":70857222},{"date":"2021-03-05","current":-7.100469,"twenty":-1.956417,"median":-0.668011,"eighty":-0.509802,"marketCap":71310013},{"date":"2021-03-12","current":-11.860366,"twenty":-1.972747,"median":-0.668372,"eighty":-0.511432,"marketCap":119113653},{"date":"2021-03-19","current":-10.39896,"twenty":-1.987553,"median":-0.66912,"eighty":-0.512296,"marketCap":104436756},{"date":"2021-03-26","current":-8.780053,"twenty":-2.013438,"median":-0.671988,"eighty":-0.512949,"marketCap":88178073},{"date":"2021-04-01","current":-9.172515,"twenty":-2.018737,"median":-0.673998,"eighty":-0.513578,"marketCap":92119571},{"date":"2021-04-09","current":-8.350152,"twenty":-2.051112,"median":-0.674717,"eighty":-0.514159,"marketCap":83860575},{"date":"2021-04-16","current":-6.848725,"twenty":-2.094781,"median":-0.676918,"eighty":-0.514473,"marketCap":68781749},{"date":"2021-04-23","current":-6.988153,"twenty":-2.163613,"median":-0.679881,"eighty":-0.515344,"marketCap":70182018},{"date":"2021-04-30","current":-7.397398,"twenty":-2.194867,"median":-0.682767,"eighty":-0.518561,"marketCap":74292068},{"date":"2021-05-07","current":-7.1178,"twenty":-2.221908,"median":-0.686065,"eighty":-0.521927,"marketCap":68437643},{"date":"2021-05-14","current":-6.893952,"twenty":-2.267386,"median":-0.689255,"eighty":-0.524028,"marketCap":66285350},{"date":"2021-05-21","current":-7.345767,"twenty":-2.382748,"median":-0.691482,"eighty":-0.52724,"marketCap":70629549},{"date":"2021-05-28","current":-7.209811,"twenty":-2.521272,"median":-0.694092,"eighty":-0.528064,"marketCap":69322328},{"date":"2021-06-04","current":-7.998083,"twenty":-2.564004,"median":-0.698842,"eighty":-0.528337,"marketCap":76901569},{"date":"2021-06-11","current":-8.930552,"twenty":-2.625887,"median":-0.7006,"eighty":-0.529142,"marketCap":85867257},{"date":"2021-06-18","current":-8.465004,"twenty":-2.675965,"median":-0.703205,"eighty":-0.532548,"marketCap":81391015},{"date":"2021-06-25","current":-8.418312,"twenty":-2.697237,"median":-0.703748,"eighty":-0.536469,"marketCap":80942070},{"date":"2021-07-02","current":-7.840154,"twenty":-2.73128,"median":-0.706976,"eighty":-0.536909,"marketCap":75383080},{"date":"2021-07-09","current":-7.511936,"twenty":-2.769358,"median":-0.711202,"eighty":-0.538469,"marketCap":72227263},{"date":"2021-07-16","current":-6.797821,"twenty":-2.77377,"median":-0.713147,"eighty":-0.539533,"marketCap":65361052},{"date":"2021-07-23","current":-7.344394,"twenty":-2.836508,"median":-0.715896,"eighty":-0.540326,"marketCap":70616345},{"date":"2021-07-30","current":-7.171358,"twenty":-2.882453,"median":-0.717756,"eighty":-0.541347,"marketCap":68952609},{"date":"2021-08-06","current":-6.637318,"twenty":-2.948541,"median":-0.718104,"eighty":-0.541544,"marketCap":65994856},{"date":"2021-08-13","current":-6.246888,"twenty":-3.050215,"median":-0.718832,"eighty":-0.541903,"marketCap":62112806},{"date":"2021-08-20","current":-5.906921,"twenty":-3.095202,"median":-0.725362,"eighty":-0.542403,"marketCap":58732517},{"date":"2021-08-27","current":-6.452727,"twenty":-3.130706,"median":-0.729547,"eighty":-0.542403,"marketCap":64159465},{"date":"2021-09-03","current":-6.726294,"twenty":-3.178396,"median":-0.729686,"eighty":-0.542403,"marketCap":66879541},{"date":"2021-09-10","current":-6.798006,"twenty":-3.194253,"median":-0.732303,"eighty":-0.542403,"marketCap":67592571},{"date":"2021-09-17","current":-6.382343,"twenty":-3.213982,"median":-0.741153,"eighty":-0.542537,"marketCap":63459639},{"date":"2021-09-24","current":-6.566935,"twenty":-3.278986,"median":-0.742349,"eighty":-0.54297,"marketCap":65295031},{"date":"2021-10-01","current":-6.030425,"twenty":-3.304661,"median":-0.747481,"eighty":-0.543109,"marketCap":59960512},{"date":"2021-10-08","current":-5.617418,"twenty":-3.334322,"median":-0.752374,"eighty":-0.543701,"marketCap":55853990},{"date":"2021-10-15","current":-5.772794,"twenty":-3.345181,"median":-0.752851,"eighty":-0.544169,"marketCap":57398887},{"date":"2021-10-22","current":-5.391659,"twenty":-3.400752,"median":-0.754125,"eighty":-0.544316,"marketCap":53609267},{"date":"2021-10-29","current":-5.492587,"twenty":-3.745956,"median":-0.764317,"eighty":-0.544913,"marketCap":54612790},{"date":"2021-11-05","current":-4.992736,"twenty":-4.551182,"median":-0.764433,"eighty":-0.545058,"marketCap":55484271},{"date":"2021-11-12","current":-4.65054,"twenty":-4.730623,"median":-0.768317,"eighty":-0.546509,"marketCap":51681446},{"date":"2021-11-19","current":-4.277451,"twenty":-4.687373,"median":-0.770925,"eighty":-0.546872,"marketCap":47535310},{"date":"2021-11-26","current":-4.063578,"twenty":-4.671179,"median":-0.774385,"eighty":-0.547752,"marketCap":45158545},{"date":"2021-12-03","current":-3.680984,"twenty":-4.657329,"median":-0.786323,"eighty":-0.548571,"marketCap":40906775},{"date":"2021-12-10","current":-3.868717,"twenty":-4.641812,"median":-0.787309,"eighty":-0.548963,"marketCap":42993047},{"date":"2021-12-17","current":-3.847329,"twenty":-4.627611,"median":-0.788987,"eighty":-0.549663,"marketCap":42755371},{"date":"2021-12-23","current":-3.938225,"twenty":-4.585205,"median":-0.79918,"eighty":-0.550108,"marketCap":43765496},{"date":"2021-12-31","current":-3.234228,"twenty":-4.516893,"median":-0.803705,"eighty":-0.55026,"marketCap":35941976},{"date":"2022-01-07","current":-3.301954,"twenty":-4.470466,"median":-0.810762,"eighty":-0.551195,"marketCap":36694619},{"date":"2022-01-14","current":-3.132044,"twenty":-4.416951,"median":-0.818396,"eighty":-0.552757,"marketCap":34806410},{"date":"2022-01-21","current":-2.977581,"twenty":-4.382338,"median":-0.823792,"eighty":-0.553146,"marketCap":33089858},{"date":"2022-01-28","current":-2.756579,"twenty":-4.314522,"median":-0.839718,"eighty":-0.55352,"marketCap":30633866},{"date":"2022-02-04","current":-2.817177,"twenty":-4.277451,"median":-0.860023,"eighty":-0.554015,"marketCap":31307283},{"date":"2022-02-11","current":-3.114222,"twenty":-4.269229,"median":-0.879323,"eighty":-0.554319,"marketCap":34608347},{"date":"2022-02-18","current":-3.003721,"twenty":-4.232683,"median":-0.896124,"eighty":-0.554405,"marketCap":33380351},{"date":"2022-02-25","current":-2.82787,"twenty":-4.218042,"median":-0.920532,"eighty":-0.554406,"marketCap":31426122},{"date":"2022-03-04","current":-2.881338,"twenty":-4.112294,"median":-0.956767,"eighty":-0.555309,"marketCap":32020313},{"date":"2022-03-11","current":-2.825494,"twenty":-4.099224,"median":-1.006209,"eighty":-0.555502,"marketCap":31399713},{"date":"2022-03-18","current":-4.775235,"twenty":-4.099224,"median":-1.037737,"eighty":-0.556101,"marketCap":68128271},{"date":"2022-03-25","current":-3.919024,"twenty":-4.099224,"median":-1.064779,"eighty":-0.556465,"marketCap":55912713},{"date":"2022-04-01","current":-3.194965,"twenty":-4.099224,"median":-1.08458,"eighty":-0.556893,"marketCap":45582566},{"date":"2022-04-08","current":-2.887351,"twenty":-4.063578,"median":-1.094696,"eighty":-0.558899,"marketCap":41193838},{"date":"2022-04-14","current":-2.942877,"twenty":-4.016051,"median":-1.111061,"eighty":-0.559105,"marketCap":41986027},{"date":"2022-04-22","current":-2.709668,"twenty":-3.997515,"median":-1.129172,"eighty":-0.559519,"marketCap":38658832},{"date":"2022-04-29","current":-2.653031,"twenty":-3.983495,"median":-1.139179,"eighty":-0.560037,"marketCap":37850799},{"date":"2022-05-06","current":-2.724105,"twenty":-3.949038,"median":-1.14331,"eighty":-0.560197,"marketCap":38864802},{"date":"2022-05-13","current":-2.54309,"twenty":-3.938819,"median":-1.151205,"eighty":-0.560273,"marketCap":36282265},{"date":"2022-05-20","current":-2.161146,"twenty":-3.926343,"median":-1.156529,"eighty":-0.56058,"marketCap":34586980},{"date":"2022-05-27","current":-2.159166,"twenty":-3.919894,"median":-1.156897,"eighty":-0.561617,"marketCap":34555292},{"date":"2022-06-03","current":-2.133426,"twenty":-3.909696,"median":-1.165802,"eighty":-0.56225,"marketCap":34143354},{"date":"2022-06-10","current":-2.078977,"twenty":-3.896879,"median":-1.16828,"eighty":-0.56264,"marketCap":33271946},{"date":"2022-06-17","current":-1.864149,"twenty":-3.879648,"median":-1.175074,"eighty":-0.563105,"marketCap":29833845},{"date":"2022-06-24","current":-1.918599,"twenty":-3.870143,"median":-1.182994,"eighty":-0.563591,"marketCap":30705253},{"date":"2022-07-01","current":-2.276975,"twenty":-3.861743,"median":-1.193251,"eighty":-0.564291,"marketCap":36440703},{"date":"2022-07-08","current":-2.351224,"twenty":-3.850491,"median":-1.193434,"eighty":-0.56495,"marketCap":37628987},{"date":"2022-07-15","current":-1.613682,"twenty":-3.844122,"median":-1.200778,"eighty":-0.565523,"marketCap":25825367},{"date":"2022-07-22","current":-1.534483,"twenty":-3.830182,"median":-1.211611,"eighty":-0.565679,"marketCap":24557865},{"date":"2022-07-29","current":-1.425584,"twenty":-3.824355,"median":-1.222168,"eighty":-0.565726,"marketCap":22815048},{"date":"2022-08-05","current":-1.435484,"twenty":-3.815486,"median":-1.229972,"eighty":-0.566106,"marketCap":22973486},{"date":"2022-08-12","current":-1.310163,"twenty":-3.80099,"median":-1.231807,"eighty":-0.567168,"marketCap":23290769},{"date":"2022-08-19","current":-1.336901,"twenty":-3.796,"median":-1.248516,"eighty":-0.56839,"marketCap":23766091},{"date":"2022-08-26","current":-1.354726,"twenty":-3.791193,"median":-1.256699,"eighty":-0.568728,"marketCap":24082972},{"date":"2022-09-02","current":-1.283425,"twenty":-3.766883,"median":-1.265958,"eighty":-0.568978,"marketCap":22815447},{"date":"2022-09-09","current":-1.274512,"twenty":-3.731346,"median":-1.2656,"eighty":-0.569201,"marketCap":22657007},{"date":"2022-09-16","current":-1.194298,"twenty":-3.702371,"median":-1.258398,"eighty":-0.569382,"marketCap":21231041},{"date":"2022-09-23","current":-0.944743,"twenty":-3.68336,"median":-1.248516,"eighty":-0.571834,"marketCap":16794704},{"date":"2022-09-30","current":-0.87879,"twenty":-3.680984,"median":-1.247774,"eighty":-0.572488,"marketCap":15622244},{"date":"2022-10-07","current":-0.944743,"twenty":-3.623359,"median":-1.238862,"eighty":-0.572707,"marketCap":16794704},{"date":"2022-10-14","current":-0.882444,"twenty":-3.598084,"median":-1.230155,"eighty":-0.573146,"marketCap":15687204},{"date":"2022-10-21","current":-0.819966,"twenty":-3.578801,"median":-1.229949,"eighty":-0.574242,"marketCap":14576536},{"date":"2022-10-28","current":-0.677363,"twenty":-3.562166,"median":-1.222168,"eighty":-0.575776,"marketCap":12041486},{"date":"2022-11-04","current":-0.643941,"twenty":-3.550284,"median":-1.211611,"eighty":-0.57763,"marketCap":11447334},{"date":"2022-11-11","current":-0.504821,"twenty":-3.533232,"median":-1.20188,"eighty":-0.575776,"marketCap":9771824},{"date":"2022-11-18","current":-0.572963,"twenty":-3.505133,"median":-1.198208,"eighty":-0.572707,"marketCap":11090842},{"date":"2022-11-25","current":-0.570917,"twenty":-3.42425,"median":-1.193434,"eighty":-0.571651,"marketCap":11051232},{"date":"2022-12-02","current":-0.589333,"twenty":-3.403021,"median":-1.191874,"eighty":-0.572357,"marketCap":11407723},{"date":"2022-12-09","current":-0.487591,"twenty":-3.400752,"median":-1.177694,"eighty":-0.569346,"marketCap":9438307},{"date":"2022-12-16","current":-0.459925,"twenty":-3.391351,"median":-1.174155,"eighty":-0.56803,"marketCap":8902777},{"date":"2022-12-23","current":-0.328234,"twenty":-3.388948,"median":-1.165893,"eighty":-0.56564,"marketCap":6353618},{"date":"2022-12-30","current":-0.355345,"twenty":-3.385925,"median":-1.16571,"eighty":-0.563708,"marketCap":6878422},{"date":"2023-01-06","current":-0.453167,"twenty":-3.379661,"median":-1.156529,"eighty":-0.561376,"marketCap":8771955},{"date":"2023-01-13","current":-0.531221,"twenty":-3.359732,"median":-1.147716,"eighty":-0.55993,"marketCap":10282849},{"date":"2023-01-20","current":-0.59693,"twenty":-3.359732,"median":-1.138353,"eighty":-0.55993,"marketCap":11554782},{"date":"2023-01-27","current":-0.707096,"twenty":-3.331421,"median":-1.101632,"eighty":-0.55993,"marketCap":13687260},{"date":"2023-02-03","current":-0.836015,"twenty":-3.315024,"median":-1.078434,"eighty":-0.55993,"marketCap":16182745},{"date":"2023-02-10","current":-0.812575,"twenty":-3.315024,"median":-1.037737,"eighty":-0.55993,"marketCap":15729023},{"date":"2023-02-17","current":-0.764758,"twenty":-3.315024,"median":-1.016045,"eighty":-0.55993,"marketCap":14803430},{"date":"2023-02-24","current":-0.735225,"twenty":-3.315024,"median":-0.956767,"eighty":-0.55993,"marketCap":14231741},{"date":"2023-03-03","current":-0.673813,"twenty":-3.305797,"median":-0.938905,"eighty":-0.55993,"marketCap":13042990},{"date":"2023-03-10","current":-0.578179,"twenty":-3.302932,"median":-0.918451,"eighty":-0.55993,"marketCap":11191820},{"date":"2023-03-17","current":-0.593805,"twenty":-3.289122,"median":-0.901567,"eighty":-0.55993,"marketCap":11494286},{"date":"2023-03-24","current":-0.483561,"twenty":-3.289122,"median":-0.880893,"eighty":-0.55886,"marketCap":9360281},{"date":"2023-03-31","current":-0.536583,"twenty":-3.284844,"median":-0.860364,"eighty":-0.555981,"marketCap":10562644},{"date":"2023-04-06","current":-0.537736,"twenty":-3.284844,"median":-0.849689,"eighty":-0.554406,"marketCap":10585330},{"date":"2023-04-14","current":-0.545496,"twenty":-3.289122,"median":-0.836015,"eighty":-0.553272,"marketCap":10738083},{"date":"2023-04-21","current":-0.545496,"twenty":-3.289122,"median":-0.822344,"eighty":-0.552002,"marketCap":10738083},{"date":"2023-04-28","current":-0.50831,"twenty":-3.289122,"median":-0.816188,"eighty":-0.548963,"marketCap":10006078},{"date":"2023-05-05","current":-0.560862,"twenty":-3.289122,"median":-0.805845,"eighty":-0.546872,"marketCap":11040564},{"date":"2023-05-12","current":-0.529208,"twenty":-3.289122,"median":-0.789136,"eighty":-0.546322,"marketCap":10417453},{"date":"2023-05-19","current":-0.539873,"twenty":-3.289122,"median":-0.786548,"eighty":-0.545058,"marketCap":10738083},{"date":"2023-05-26","current":-0.504896,"twenty":-3.289122,"median":-0.771626,"eighty":-0.543556,"marketCap":10042376},{"date":"2023-06-02","current":-0.485962,"twenty":-3.293399,"median":-0.76666,"eighty":-0.54247,"marketCap":9665787},{"date":"2023-06-08","current":-0.533866,"twenty":-3.297677,"median":-0.764433,"eighty":-0.542403,"marketCap":10618603},{"date":"2023-06-16","current":-0.53227,"twenty":-3.301954,"median":-0.758263,"eighty":-0.540326,"marketCap":10586842},{"date":"2023-06-23","current":-0.502158,"twenty":-3.303142,"median":-0.752851,"eighty":-0.538322,"marketCap":9987929},{"date":"2023-06-30","current":-0.699554,"twenty":-3.30433,"median":-0.747625,"eighty":-0.537275,"marketCap":13914136},{"date":"2023-07-07","current":-0.623592,"twenty":-3.30433,"median":-0.742349,"eighty":-0.537275,"marketCap":12403242},{"date":"2023-07-14","current":-0.553941,"twenty":-3.30433,"median":-0.735004,"eighty":-0.537275,"marketCap":11017878},{"date":"2023-07-21","current":-0.539113,"twenty":-3.30433,"median":-0.729628,"eighty":-0.536494,"marketCap":10722959},{"date":"2023-07-28","current":-0.481324,"twenty":-3.30433,"median":-0.724498,"eighty":-0.534659,"marketCap":9573530},{"date":"2023-08-04","current":-0.49425,"twenty":-3.30433,"median":-0.720134,"eighty":-0.53286,"marketCap":9830639},{"date":"2023-08-11","current":-0.53295,"twenty":-3.30433,"median":-0.717872,"eighty":-0.53227,"marketCap":10924412},{"date":"2023-08-18","current":-0.440744,"twenty":-3.30433,"median":-0.716071,"eighty":-0.531268,"marketCap":9034369},{"date":"2023-08-25","current":-0.436504,"twenty":-3.30433,"median":-0.714981,"eighty":-0.528148,"marketCap":8947451},{"date":"2023-09-01","current":-0.436504,"twenty":-3.30433,"median":-0.711312,"eighty":-0.523809,"marketCap":8947451},{"date":"2023-09-08","current":-0.422369,"twenty":-3.30433,"median":-0.709081,"eighty":-0.522306,"marketCap":8657724},{"date":"2023-09-15","current":-0.447479,"twenty":-3.30433,"median":-0.709081,"eighty":-0.517062,"marketCap":9172416},{"date":"2023-09-22","current":-0.430517,"twenty":-3.30433,"median":-0.709081,"eighty":-0.514706,"marketCap":8824743},{"date":"2023-09-29","current":-0.415801,"twenty":-3.305519,"median":-0.711004,"eighty":-0.51278,"marketCap":8523086},{"date":"2023-10-06","current":-0.407403,"twenty":-3.305519,"median":-0.705538,"eighty":-0.509488,"marketCap":8350954},{"date":"2023-10-13","current":-0.394932,"twenty":-3.305519,"median":-0.70319,"eighty":-0.508104,"marketCap":8095313},{"date":"2023-10-20","current":-0.374146,"twenty":-3.305519,"median":-0.70319,"eighty":-0.507081,"marketCap":7669244},{"date":"2023-10-27","current":-0.374146,"twenty":-3.31146,"median":-0.703469,"eighty":-0.505133,"marketCap":7669244},{"date":"2023-11-03","current":-0.374146,"twenty":-3.31146,"median":-0.703469,"eighty":-0.503666,"marketCap":7669244},{"date":"2023-11-10","current":-0.374146,"twenty":-3.31146,"median":-0.70319,"eighty":-0.501843,"marketCap":7669244},{"date":"2023-11-17","current":-0.351002,"twenty":-3.31146,"median":-0.697375,"eighty":-0.499296,"marketCap":6650086},{"date":"2023-11-24","current":-0.474857,"twenty":-3.31146,"median":-0.691269,"eighty":-0.497519,"marketCap":9169007},{"date":"2023-12-01","current":-0.528697,"twenty":-3.31146,"median":-0.684846,"eighty":-0.496211,"marketCap":10208616},{"date":"2023-12-08","current":-0.52958,"twenty":-3.307895,"median":-0.679746,"eighty":-0.496235,"marketCap":10225659},{"date":"2023-12-15","current":-0.518547,"twenty":-3.307895,"median":-0.675604,"eighty":-0.494662,"marketCap":10012624},{"date":"2023-12-22","current":-0.450143,"twenty":-3.307895,"median":-0.673813,"eighty":-0.494275,"marketCap":8691810},{"date":"2023-12-29","current":-0.390036,"twenty":-3.31146,"median":-0.671761,"eighty":-0.494091,"marketCap":7531197},{"date":"2024-01-05","current":-0.394272,"twenty":-3.315024,"median":-0.66912,"eighty":-0.493262,"marketCap":7613003},{"date":"2024-01-12","current":-0.370794,"twenty":-3.315024,"median":-0.668011,"eighty":-0.491925,"marketCap":7159665},{"date":"2024-01-19","current":-0.366293,"twenty":-3.318589,"median":-0.667779,"eighty":-0.490835,"marketCap":7072747},{"date":"2024-01-26","current":-0.372824,"twenty":-3.315024,"median":-0.664015,"eighty":-0.4874,"marketCap":7198863},{"date":"2024-02-02","current":-0.455086,"twenty":-3.315024,"median":-0.660462,"eighty":-0.48591,"marketCap":8787249},{"date":"2024-02-09","current":-0.472562,"twenty":-3.315024,"median":-0.658221,"eighty":-0.484311,"marketCap":9124696},{"date":"2024-02-16","current":-0.41572,"twenty":-3.315024,"median":-0.656727,"eighty":-0.483435,"marketCap":8027142},{"date":"2024-02-23","current":-0.433285,"twenty":-3.315024,"median":-0.655171,"eighty":-0.482634,"marketCap":8366293},{"date":"2024-03-01","current":-0.410424,"twenty":-3.31146,"median":-0.652353,"eighty":-0.480846,"marketCap":7924885},{"date":"2024-03-08","current":-0.406011,"twenty":-3.31146,"median":-0.649964,"eighty":-0.476369,"marketCap":7839671},{"date":"2024-03-15","current":-0.364616,"twenty":-3.31146,"median":-0.648423,"eighty":-0.474686,"marketCap":7040366},{"date":"2024-03-22","current":-0.443876,"twenty":-3.31146,"median":-0.645425,"eighty":-0.47327,"marketCap":8570806},{"date":"2024-03-28","current":-0.452789,"twenty":-3.31146,"median":-0.644454,"eighty":-0.471532,"marketCap":8308229},{"date":"2024-04-05","current":-0.401856,"twenty":-3.315024,"median":-0.641005,"eighty":-0.468806,"marketCap":7373661},{"date":"2024-04-12","current":-0.411202,"twenty":-3.315024,"median":-0.63863,"eighty":-0.465918,"marketCap":7545141},{"date":"2024-04-19","current":-0.418678,"twenty":-3.315024,"median":-0.636957,"eighty":-0.462258,"marketCap":7682325},{"date":"2024-04-26","current":-0.383119,"twenty":-3.31146,"median":-0.634914,"eighty":-0.458969,"marketCap":7029842},{"date":"2024-05-03","current":-0.390642,"twenty":-3.31146,"median":-0.632448,"eighty":-0.457367,"marketCap":7167884},{"date":"2024-05-10","current":-0.363932,"twenty":-3.31146,"median":-0.631649,"eighty":-0.455239,"marketCap":6927811},{"date":"2024-05-17","current":-0.336907,"twenty":-3.31146,"median":-0.627161,"eighty":-0.452468,"marketCap":6413370},{"date":"2024-05-24","current":-0.300421,"twenty":-3.31146,"median":-0.62339,"eighty":-0.450143,"marketCap":5718809},{"date":"2024-05-31","current":-0.242606,"twenty":-3.31146,"median":-0.62339,"eighty":-0.449152,"marketCap":4618241},{"date":"2024-06-07","current":-0.242787,"twenty":-3.31146,"median":-0.62339,"eighty":-0.446856,"marketCap":4621696},{"date":"2024-06-14","current":-0.218735,"twenty":-3.315024,"median":-0.623592,"eighty":-0.443857,"marketCap":4163846},{"date":"2024-06-21","current":-0.222547,"twenty":-3.318589,"median":-0.62339,"eighty":-0.441359,"marketCap":4236411},{"date":"2024-06-28","current":-0.220641,"twenty":-3.32857,"median":-0.625058,"eighty":-0.440638,"marketCap":4200128},{"date":"2024-07-05","current":-0.208752,"twenty":-3.32857,"median":-0.619265,"eighty":-0.43957,"marketCap":3973795},{"date":"2024-07-12","current":-0.23598,"twenty":-3.32857,"median":-0.616695,"eighty":-0.436682,"marketCap":4492116},{"date":"2024-07-15","current":-0.23598,"twenty":-3.32857,"median":-0.615556,"eighty":-0.436504,"marketCap":4492116},{"date":"2024-08-02","current":-0.198042,"twenty":-3.380136,"median":-0.617262,"eighty":-0.435015,"marketCap":3769922},{"date":"2024-08-09","current":-0.190599,"twenty":-3.380136,"median":-0.617262,"eighty":-0.432566,"marketCap":3628247},{"date":"2024-08-16","current":-0.154796,"twenty":-3.380136,"median":-0.617262,"eighty":-0.431604,"marketCap":3446835},{"date":"2024-08-23","current":-0.146835,"twenty":-3.380136,"median":-0.617262,"eighty":-0.430459,"marketCap":3269573},{"date":"2024-08-30","current":-0.212183,"twenty":-3.380136,"median":-0.617262,"eighty":-0.428972,"marketCap":4724670},{"date":"2024-09-06","current":-0.145368,"twenty":-3.380136,"median":-0.617262,"eighty":-0.427851,"marketCap":3236901},{"date":"2024-09-13","current":-0.162523,"twenty":-3.380136,"median":-0.617262,"eighty":-0.424552,"marketCap":3618896},{"date":"2024-09-20","current":-0.1711,"twenty":-3.380136,"median":-0.610449,"eighty":-0.423664,"marketCap":3809893},{"date":"2024-09-27","current":-0.124035,"twenty":-3.380136,"median":-0.610449,"eighty":-0.420134,"marketCap":2761878},{"date":"2024-10-04","current":-0.108834,"twenty":-3.380136,"median":-0.610449,"eighty":-0.418838,"marketCap":2423412},{"date":"2024-10-11","current":-0.159206,"twenty":-3.380136,"median":-0.610449,"eighty":-0.416624,"marketCap":3545040},{"date":"2024-10-18","current":-0.14798,"twenty":-3.380136,"median":-0.610449,"eighty":-0.415718,"marketCap":3295069},{"date":"2024-10-25","current":-0.153083,"twenty":-3.380136,"median":-0.610449,"eighty":-0.413435,"marketCap":3408693},{"date":"2024-10-31","current":-0.151042,"twenty":-3.380136,"median":-0.610449,"eighty":-0.411202,"marketCap":3363243},{"date":"2024-11-08","current":-0.220439,"twenty":-3.380374,"median":-0.611466,"eighty":-0.40952,"marketCap":4908517},{"date":"2024-11-15","current":-0.114938,"twenty":-3.380374,"median":-0.611466,"eighty":-0.407403,"marketCap":3067823},{"date":"2024-11-22","current":-0.125524,"twenty":-3.380374,"median":-0.611466,"eighty":-0.406011,"marketCap":3350351},{"date":"2024-11-29","current":-0.150115,"twenty":-3.380374,"median":-0.611466,"eighty":-0.405129,"marketCap":4006726},{"date":"2024-12-06","current":-0.134478,"twenty":-3.380374,"median":-0.611466,"eighty":-0.401856,"marketCap":3589359},{"date":"2024-12-13","current":-0.124054,"twenty":-3.380374,"median":-0.611466,"eighty":-0.398663,"marketCap":3311114},{"date":"2024-12-20","current":-0.119884,"twenty":-3.380374,"median":-0.611466,"eighty":-0.397185,"marketCap":3199816},{"date":"2024-12-27","current":-0.16471,"twenty":-3.380374,"median":-0.611466,"eighty":-0.396832,"marketCap":4396269},{"date":"2025-01-03","current":-0.172007,"twenty":-3.380374,"median":-0.611466,"eighty":-0.394932,"marketCap":4591040},{"date":"2025-01-10","current":-0.153243,"twenty":-3.381087,"median":-0.612657,"eighty":-0.392417,"marketCap":4090200},{"date":"2025-01-17","current":-0.149073,"twenty":-3.381087,"median":-0.612657,"eighty":-0.390751,"marketCap":3978902},{"date":"2025-01-24","current":-0.142818,"twenty":-3.381087,"median":-0.612657,"eighty":-0.389803,"marketCap":3811955},{"date":"2025-01-31","current":-0.133436,"twenty":-3.381087,"median":-0.612657,"eighty":-0.385763,"marketCap":3561534},{"date":"2025-02-07","current":-0.154285,"twenty":-3.381087,"median":-0.60887,"eighty":-0.382418,"marketCap":4118024},{"date":"2025-02-14","current":-0.179304,"twenty":-3.381087,"median":-0.607721,"eighty":-0.379483,"marketCap":4785812},{"date":"2025-02-21","current":-0.167837,"twenty":-3.381087,"median":-0.607721,"eighty":-0.376607,"marketCap":4479742},{"date":"2025-02-28","current":-0.145945,"twenty":-3.381087,"median":-0.607721,"eighty":-0.374146,"marketCap":3895428},{"date":"2025-03-07","current":-0.146988,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373785,"marketCap":3923253},{"date":"2025-03-14","current":-0.120396,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373039,"marketCap":3088518},{"date":"2025-03-21","current":-0.130158,"twenty":-3.3818,"median":-0.608308,"eighty":-0.373039,"marketCap":3338938},{"date":"2025-03-28","current":-0.131242,"twenty":-3.3818,"median":-0.608308,"eighty":-0.372688,"marketCap":3366763},{"date":"2025-04-04","current":-0.127989,"twenty":-3.3818,"median":-0.608308,"eighty":-0.372688,"marketCap":3283289},{"date":"2025-04-11","current":-0.126904,"twenty":-3.381087,"median":-0.607721,"eighty":-0.3724,"marketCap":3255465},{"date":"2025-04-17","current":-0.143195,"twenty":-3.381087,"median":-0.607721,"eighty":-0.370776,"marketCap":3673389},{"date":"2025-04-25","current":-0.153272,"twenty":-3.3818,"median":-0.608308,"eighty":-0.370706,"marketCap":3931878},{"date":"2025-05-02","current":-0.151851,"twenty":-3.3818,"median":-0.608308,"eighty":-0.366293,"marketCap":3895428},{"date":"2025-05-09","current":-0.069765,"twenty":-3.3818,"median":-0.608308,"eighty":-0.363401,"marketCap":1789671},{"date":"2025-05-16","current":-0.104097,"twenty":-3.3818,"median":-0.608308,"eighty":-0.357147,"marketCap":2582859},{"date":"2025-05-23","current":-0.089207,"twenty":-3.3818,"median":-0.608308,"eighty":-0.345815,"marketCap":2213401},{"date":"2025-05-30","current":-0.086956,"twenty":-3.3818,"median":-0.608308,"eighty":-0.336471,"marketCap":2157553},{"date":"2025-06-06","current":-0.155412,"twenty":-3.3818,"median":-0.608308,"eighty":-0.328428,"marketCap":3856071},{"date":"2025-06-13","current":-0.164848,"twenty":-3.3818,"median":-0.608308,"eighty":-0.307874,"marketCap":4090219},{"date":"2025-06-20","current":-0.148812,"twenty":-3.382513,"median":-0.607721,"eighty":-0.253225,"marketCap":3692332},{"date":"2025-06-27","current":-0.145249,"twenty":-3.382513,"median":-0.601576,"eighty":-0.23981,"marketCap":3603912},{"date":"2025-07-03","current":-0.161746,"twenty":-3.382513,"median":-0.592593,"eighty":-0.23598,"marketCap":4013243},{"date":"2025-07-11","current":-0.171641,"twenty":-3.382513,"median":-0.57922,"eighty":-0.227685,"marketCap":4258749},{"date":"2025-07-18","current":-0.17416,"twenty":-3.382513,"median":-0.575195,"eighty":-0.221331,"marketCap":4321253},{"date":"2025-07-25","current":-0.18033,"twenty":-3.382513,"median":-0.567502,"eighty":-0.218282,"marketCap":4474354},{"date":"2025-08-01","current":-0.162914,"twenty":-3.382513,"median":-0.563857,"eighty":-0.21025,"marketCap":4042229},{"date":"2025-08-08","current":-0.142395,"twenty":-3.382513,"median":-0.559832,"eighty":-0.201865,"marketCap":3533100},{"date":"2025-08-15","current":-0.141271,"twenty":-3.382513,"median":-0.552295,"eighty":-0.197588,"marketCap":4175109},{"date":"2025-08-22","current":-0.139484,"twenty":-3.382513,"median":-0.546449,"eighty":-0.189036,"marketCap":4122320},{"date":"2025-08-29","current":-0.134386,"twenty":-3.382513,"median":-0.540844,"eighty":-0.185506,"marketCap":3971632},{"date":"2025-09-05","current":-0.126721,"twenty":-3.383226,"median":-0.539113,"eighty":-0.183327,"marketCap":3745120},{"date":"2025-09-12","current":-0.136594,"twenty":-3.382513,"median":-0.536517,"eighty":-0.180793,"marketCap":4036898},{"date":"2025-09-19","current":-0.134158,"twenty":-3.382513,"median":-0.534056,"eighty":-0.178011,"marketCap":3964913},{"date":"2025-09-26","current":-0.126526,"twenty":-3.382513,"median":-0.53303,"eighty":-0.175763,"marketCap":3739362},{"date":"2025-10-03","current":-0.131852,"twenty":-3.382513,"median":-0.53227,"eighty":-0.172728,"marketCap":3896768},{"date":"2025-10-10","current":-0.15897,"twenty":-3.382513,"median":-0.53227,"eighty":-0.171412,"marketCap":4698197},{"date":"2025-10-17","current":-0.140004,"twenty":-3.382513,"median":-0.53227,"eighty":-0.170011,"marketCap":4137677},{"date":"2025-10-24","current":-0.111068,"twenty":-3.382513,"median":-0.53227,"eighty":-0.166945,"marketCap":3282499},{"date":"2025-10-31","current":-0.105222,"twenty":-3.382513,"median":-0.53227,"eighty":-0.163465,"marketCap":3109736},{"date":"2025-11-07","current":-0.088757,"twenty":-3.382513,"median":-0.53227,"eighty":-0.161746,"marketCap":2623120},{"date":"2025-11-14","current":-0.313947,"twenty":-3.382513,"median":-0.531784,"eighty":-0.161746,"marketCap":9278401},{"date":"2025-11-21","current":-0.276075,"twenty":-3.382513,"median":-0.52958,"eighty":-0.161746,"marketCap":7230405},{"date":"2025-11-28","current":-0.347703,"twenty":-3.382513,"median":-0.526633,"eighty":-0.161746,"marketCap":9106329},{"date":"2025-12-05","current":-0.311245,"twenty":-3.382513,"median":-0.522447,"eighty":-0.161746,"marketCap":8151497},{"date":"2025-12-12","current":-0.29965,"twenty":-3.382513,"median":-0.518527,"eighty":-0.161746,"marketCap":7847840},{"date":"2025-12-19","current":-0.225575,"twenty":-3.382513,"median":-0.514773,"eighty":-0.161746,"marketCap":5907811},{"date":"2025-12-26","current":-0.250696,"twenty":-3.382513,"median":-0.51073,"eighty":-0.161746,"marketCap":6565734},{"date":"2026-01-02","current":-0.271051,"twenty":-3.382513,"median":-0.509351,"eighty":-0.161746,"marketCap":7098820},{"date":"2026-01-09","current":-0.282645,"twenty":-3.382513,"median":-0.506297,"eighty":-0.161746,"marketCap":7402477},{"date":"2026-01-16","current":-0.282117,"twenty":-3.382513,"median":-0.503101,"eighty":-0.161746,"marketCap":7388656},{"date":"2026-01-23","current":-0.281709,"twenty":-3.382513,"median":-0.502006,"eighty":-0.161746,"marketCap":7377958},{"date":"2026-01-30","current":-0.253933,"twenty":-3.334273,"median":-0.494301,"eighty":-0.161746,"marketCap":6650504},{"date":"2026-02-06","current":-0.272178,"twenty":-3.252764,"median":-0.492695,"eighty":-0.161746,"marketCap":7128342},{"date":"2026-02-13","current":-0.245763,"twenty":-3.208088,"median":-0.491105,"eighty":-0.161746,"marketCap":6436546},{"date":"2026-02-20","current":-0.267821,"twenty":-3.135609,"median":-0.486305,"eighty":-0.161746,"marketCap":7014231}],"updateTime":1771697495143},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TOVX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612449137","title":"BRIEF-Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2612449137","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612449137?lang=en_us&edition=fundamental","pubTime":"2026-02-18 22:02","pubTimestamp":1771423355,"startTime":"0","endTime":"0","summary":"BRIEF-Theriva Biologics Licenses Syn-020 To Rasayana Therapeutics For Multiple IndicationsFeb 18 (Reuters) - Theriva Biologics Inc TOVX.A:THERIVA BIOLOGICS LICENSES SYN-020 TO RASAYANA THERAPEUTICS FO","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZE02I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2612463244","title":"Theriva Biologics licenses SYN-020 to Rasayana Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2612463244","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612463244?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:16","pubTimestamp":1771420604,"startTime":"0","endTime":"0","summary":"Theriva Biologics (TOVX) reported the out-licensing of SYN-020, to Rasayana Therapeutics, a privately-held company targeting the Gut-Organ axis bio...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-licenses-syn-020-to-rasayana-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-licenses-syn-020-to-rasayana-therapeutics-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","TOVX","BK4139","BK4007","LENZ"],"gpt_icon":0},{"id":"2612451754","title":"Theriva Biologics Inc: Received $300,000 Upfront Payment at Signing & Eligible for up to $38M in Milestone Payments","url":"https://stock-news.laohu8.com/highlight/detail?id=2612451754","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612451754?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:04","pubTimestamp":1771419847,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZE02I:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2612445173","title":"Theriva™ Biologics Licenses Syn-020 to Rasayana Therapeutics for Multiple Indications","url":"https://stock-news.laohu8.com/highlight/detail?id=2612445173","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612445173?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:04","pubTimestamp":1771419847,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nFWN3ZE02I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2612971445","title":"Theriva Biologics Licenses SYN-020 to Rasayana Therapeutics in $38M Milestone Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2612971445","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612971445?lang=en_us&edition=fundamental","pubTime":"2026-02-18 21:01","pubTimestamp":1771419696,"startTime":"0","endTime":"0","summary":"Theriva Biologics said it has out-licensed SYN-020 to Rasayana Therapeutics under an exclusive worldwide agreement with sublicensing rights. Theriva received a $300,000 upfront payment and said it is eligible for up to $38 million in development, regulatory, and sales milestones, plus tiered single-digit royalties on net product sales. Rasayana will assume responsibility and costs for development and commercialization of SYN-020.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 18, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260218:nNDL7xfPNk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","SG9999014013.SGD","LU2095319765.USD","BK4139","LU2210150020.SGD","SG9999014039.USD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","SG9999014005.SGD","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4585","SG9999014021.USD","IE00BKPKM429.USD","TOVX"],"gpt_icon":0},{"id":"2610929157","title":"Theriva Biologics Delays Shareholder Vote on Issuance of 16.2 Million Warrant Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2610929157","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610929157?lang=en_us&edition=fundamental","pubTime":"2026-02-12 21:08","pubTimestamp":1770901693,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. announced that it was unable to convene its Special Meeting of Stockholders on February 11, 2026, due to a lack of quorum. The meeting was intended to seek shareholder approval for the issuance of up to 16,184,560 shares of common stock upon the exercise of common stock purchase warrants issued under a warrant inducement agreement with certain institutional investors. The company will reschedule the meeting and continue to call additional meetings every 60 days, as required by the agreement, until the necessary approval is obtained or the warrants are no longer outstanding.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via EDG","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL4wks04:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2608306879","title":"Theriva Biologics stellt Phase-1-Studienergebnisse zu VCN-01 bei refraktärem Retinoblastom vor","url":"https://stock-news.laohu8.com/highlight/detail?id=2608306879","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608306879?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:01","pubTimestamp":1770123677,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. hat die bevorstehende Prsentation von Daten aus einer Phase-1-Studie zur Sicherheit und Wirksamkeit von VCN-01  bei pdiatrischen Patienten mit refraktrem intraokulrem Retinoblastom angekündigt. Die Ergebnisse der Studie sowie prklinische Daten zur Kombination von VCN-01 mit Topotecan werden im Rahmen des 41. Asia-Pacific Academy of Ophthalmology  Kongresses am 7. Februar 2026 in Hongkong vorgestellt.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via GlobeNewswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL6KFhWG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BKPKM429.USD","IE00B3QW5Z07.USD","TOVX","SG9999014021.USD","SG9999014039.USD","LU2095319765.USD","SG9999014013.SGD","LU2210149790.SGD","BK4112","NDAQ","IE00B64PRP62.GBP","LU2210150020.SGD","BK4585","BK4588","LU0314104364.USD","SG9999014005.SGD","IE00BGHQF748.EUR","BK4139"],"gpt_icon":0},{"id":"2608798658","title":"Theriva™ Biologics Announces Upcoming Presentation of Data From Vcn-01 Retinoblastoma Phase 1 Clinical Trial at Apao 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2608798658","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608798658?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:00","pubTimestamp":1770123605,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nTUA4BDYMT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2595734835","title":"Why Is Theriva Biologics Stock Gaining Monday?","url":"https://stock-news.laohu8.com/highlight/detail?id=2595734835","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595734835?lang=en_us&edition=fundamental","pubTime":"2025-12-30 00:41","pubTimestamp":1767026460,"startTime":"0","endTime":"0","summary":"Theriva Biologics stock rose on Monday as it received positive Scientific Advice from CHMP for a Phase 3 trial of VCN-01 for PDAC treatment.","market":"hk","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/12/29/Tumor-Microenvironment-Concept-With-Canc.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/12/29/Tumor-Microenvironment-Concept-With-Canc.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/12/49613988/why-is-theriva-biologics-stock-gaining-monday","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/12/49613988/why-is-theriva-biologics-stock-gaining-monday","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["CHMP","LU1861219969.SGD","LU1861215975.USD","LU0724618433.USD","LU1861220033.SGD","BK4512","LU2357305700.SGD","ON","IE00BD6J9T35.USD","LU1854103824.USD","LU1720051108.HKD","BK4139","IE00BZ199S13.USD","BK4605","BK4141","IE00BFMHRM44.USD","BK4588","MAA","LU1548497426.USD","BK4081","LU0348723411.USD","LU1720051017.SGD","TOVX","LU1861214812.USD","LU1854104046.USD","LU1978683503.SGD","LU2298322129.HKD","BK4087","LU2360107325.USD","LU0124384867.USD","EMA","BK4215","BK4585"],"gpt_icon":0},{"id":"2595804127","title":"Theriva Biologics Inc - Cash Runway Until Q1 2027 Supports Vcn-01 Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2595804127","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595804127?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:00","pubTimestamp":1767013200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA8NP259:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2595780483","title":"Theriva™ Biologics Announces Positive Scientific Advice From the European Medicines Agency (Ema) on the Design of a Phase 3 Trial of Vcn-01 in Metastatic Pancreatic Ductal Adenocarcinoma (Pdac)","url":"https://stock-news.laohu8.com/highlight/detail?id=2595780483","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595780483?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:00","pubTimestamp":1767013200,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA8NP259:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2595578043","title":"Theriva Biologics Inc - to Schedule End-of-Phase 2 Meeting With FDA in H1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2595578043","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595578043?lang=en_us&edition=fundamental","pubTime":"2025-12-29 21:00","pubTimestamp":1767013200,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nTUA8NP259:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2591273756","title":"Theriva Biologics Seeks Shareholder Approval for Issuance of 16.2 Million Shares Under Warrant Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2591273756","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591273756?lang=en_us&edition=fundamental","pubTime":"2025-12-16 06:22","pubTimestamp":1765837344,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. announced that it was unable to convene its Special Meeting of Stockholders on December 15, 2025, due to a lack of quorum. The meeting was called to seek shareholder approval for the issuance of up to 16,184,560 shares of common stock upon the exercise of certain purchase warrants issued under a warrant inducement agreement with institutional investors. The company is required to call additional stockholder meetings every 60 days until approval is obtained or the warrants are no longer outstanding. The date and time of a new special meeting will be announced, and new proxy materials will be filed and mailed as required.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDL995W06:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2582737149","title":"Theriva Biologics reports Q3 EPS (45c) vs ($6.81) last year","url":"https://stock-news.laohu8.com/highlight/detail?id=2582737149","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582737149?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:16","pubTimestamp":1762953378,"startTime":"0","endTime":"0","summary":"“Recent presentations of clinical data for VCN-01 and preclinical data for VCN-12 at medical congresses have highlighted the progress made across o...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-reports-q3-eps-45c-vs-6-81-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-reports-q3-eps-45c-vs-6-81-last-year-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX"],"gpt_icon":0},{"id":"2582716313","title":"Theriva Biologics Q3 EPS $(0.45) Beats $(1.13) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2582716313","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582716313?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:14","pubTimestamp":1762953243,"startTime":"0","endTime":"0","summary":"Theriva Biologics (AMEX:TOVX) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(1.13) by 60.18 percent. This is a 93.39 percent increase over losses of $(6.81) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/11/48800856/theriva-biologics-q3-eps-0-45-beats-1-13-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX"],"gpt_icon":0},{"id":"2582797613","title":"Theriva Biologics reports third quarter loss and lower R&D expenses","url":"https://stock-news.laohu8.com/highlight/detail?id=2582797613","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582797613?lang=en_us&edition=fundamental","pubTime":"2025-11-12 21:02","pubTimestamp":1762952529,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. reported cash and cash equivalents of $7.5 million as of September 30, 2025, compared to $11.6 million as of December 31, 2024. Following recent capital raises, cash increased to $15.5 million as of November 10, 2025, extending the cash runway into the first quarter of 2027. During the period, the company presented expanded Phase 2b clinical trial data for VCN-01 in metastatic pancreatic ductal adenocarcinoma at the European Society for Medical Oncology Annual Congress, and preclinical data for VCN-12 at the European Society of Gene & Cell Therapy Annual Congress. Theriva is preparing for regulatory discussions on a proposed Phase 3 study of VCN-01 in metastatic PDAC and a potential Phase 2/3 trial in retinoblastoma. Additional funding will be required to initiate new VCN-01 clinical trials.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL1kXwfy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","LU2095319765.USD","BK4139","LU2210150020.SGD","BK4112","IE00B64PRP62.GBP","IE00BGHQF748.EUR","NDAQ","BK4588","LU2210149790.SGD","LU0314104364.USD","BK4585","IE00BKPKM429.USD","TOVX"],"gpt_icon":0},{"id":"2580154634","title":"Theriva Biologics Inc. Announces Date for Upcoming Special Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2580154634","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580154634?lang=en_us&edition=fundamental","pubTime":"2025-11-01 04:05","pubTimestamp":1761941157,"startTime":"0","endTime":"0","summary":"Theriva Biologics Inc. has announced that it will hold a Special Meeting of Stockholders on December 15, 2025, at its principal office in Rockville, Maryland.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Theriva Biologics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 31, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251031:nNDLc5Cvd6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2578428995","title":"Theriva Biologics: No Material Development to Account for Stock Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2578428995","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578428995?lang=en_us&edition=fundamental","pubTime":"2025-10-25 03:01","pubTimestamp":1761332460,"startTime":"0","endTime":"0","summary":"Theriva Biologics, whose shares rose sharply Friday, said there has been no reason to account for the unusual market action.The company added that there wasn't any material development in its business and affairs not previously disclosed.Theriva's response to the unusual market action was pursuant to Section 401 of the NYSE Company Guide, it said.The stock was recently up 44%, to 49 cents, on volume of more than 479 million shares, compared with a 65-day average of 4.9 million shares.On Monday, expanded metastatic pancreatic ductal adenocarcinoma data from Theriva's VIRAGE Phase 2b trial was presented at the European Society for Medical Oncology Annual Congress.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TOVX"],"gpt_icon":0},{"id":"2578444645","title":"Theriva Biologics sees no material development to account for unusual trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2578444645","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578444645?lang=en_us&edition=fundamental","pubTime":"2025-10-25 02:40","pubTimestamp":1761331209,"startTime":"0","endTime":"0","summary":"Theriva Biologics (TOVX) announced that the company had become aware of unusual trading activity in its common stock on the NYSE American on Octobe...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/theriva-biologics-sees-no-material-development-to-account-for-unusual-trading-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/theriva-biologics-sees-no-material-development-to-account-for-unusual-trading-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TOVX","BK4139"],"gpt_icon":0},{"id":"2578826542","title":"Theriva Biologics Provides Response to Unusual Market Action","url":"https://stock-news.laohu8.com/highlight/detail?id=2578826542","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2578826542?lang=en_us&edition=fundamental","pubTime":"2025-10-25 02:31","pubTimestamp":1761330660,"startTime":"0","endTime":"0","summary":"ROCKVILLE, Md., Oct.  24, 2025  (GLOBE NEWSWIRE) -- Theriva Biologics (NYSE American: TOVX), (“Theriva” or the “Company”), a diversified clinical-stage company developing therapeutics designed to trea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/10/24/3173023/0/en/Theriva-Biologics-Provides-Response-to-Unusual-Market-Action.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TOVX","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":30,"code":"91000000","status":"200"}]}}